Clinical Trial

Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this prospective cohort study is to collect the multi-omics profile of cardiovascular disease (CVD) high-risk individuals in Harbin, and to discover novel biomarker signatures of major adverse cardiovascular events (MACE) during a minimum 2-year follow-up period.
Trial Details
NCT Number NCT07033624
Lead Sponsor Harbin Medical University
Conditions Cardiovascular Diseases
Enrollment 10,000 participants
Start Date 2025-07-01
Primary Completion 2027-07-01 (estimated)
Study Completion 2047-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-24